TY  - JOUR

T1  - POSC4 Modeling Health-Related Outcomes With Avelumab as a First-Line Maintenance Treatment Following Chemotherapy vs. Best Supportive Care (BSC) for Patients With Locally Advanced or Metastatic Urothelial Cancer in the UK

JO  - Value in Health

PY  - 2022/01/01

AU  - Critchlow S

AU  - Xiao Y

AU  - Crabb S

AU  - Eccleston A

AU  - Christoforou K

AU  - Amin A

AU  - Bullement A

AU  - Deighton K

AU  - Chang J

AU  - Kearney M

AU  - Kapetanakis V et al

ED  - 

DO  - DOI: 10.1016/j.jval.2021.11.150

PB  - Elsevier BV

VL  - 25

IS  - 1

SP  - S32

EP  - S33

Y2  - 2024/12/26

ER  -